OTCMKTS:OXBDF Oxford Biomedica (OXBDF) Stock Price, News & Analysis → Bigger Than NVIDIA? (From Behind the Markets) (Ad) Free OXBDF Stock Alerts $4.10 0.00 (0.00%) (As of 06/17/2024 ET) Add Compare Share Share Today's Range$4.10▼$4.1050-Day Range$2.62▼$4.4052-Week Range$2.09▼$6.02VolumeN/AAverage Volume190 shsMarket Capitalization$394.67 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest Get Oxford Biomedica alerts: Email Address Ad Behind the MarketsBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ONE stock you should be watching.Get the full story here >>> About Oxford Biomedica Stock (OTCMKTS:OXBDF)Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, and adenoviral vectors. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.Read More OXBDF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OXBDF Stock News HeadlinesMay 1, 2024 | finance.yahoo.comOxford Biomedica Full Year 2023 Earnings: Misses ExpectationsApril 30, 2024 | msn.comOxford Biomedica plc GAAP EPS of -163.11p, revenue of £89.5MJune 18, 2024 | Behind the Markets (Ad)Bigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ONE stock you should be watching.April 29, 2024 | lse.co.ukSMALL-CAP WINNERS & LOSERS: Oxford BioMedica bullish; Petrofac slumpsApril 20, 2024 | barrons.comOxford BioMedica PLCMarch 30, 2024 | finance.yahoo.comOxford Biomedica Insiders Placed Bullish Bets Worth UK£415.3kJanuary 23, 2024 | investing.comOxford BioMedica PLC (OXB)January 23, 2024 | finance.yahoo.comOxford Biomedica is hosting a free webinar to share clients’ success stories in viral vector manufacturingJune 18, 2024 | Behind the Markets (Ad)Bigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ONE stock you should be watching.November 5, 2023 | morningstar.comOxford BioMedica PLC OXOASeptember 25, 2023 | finance.yahoo.comAnalysts Just Slashed Their Oxford Biomedica plc (LON:OXB) EPS NumbersSeptember 21, 2023 | msn.comOxford BioMedica shares boom as manufacturer expands complex cancer therapiesSeptember 20, 2023 | lse.co.ukOxford BioMedica shares up, in talks to buy ABL Europe but loss widensSeptember 20, 2023 | msn.comOxford Biomedica stock soars on rosy forecast, talks to buy ABL EuropeSeptember 20, 2023 | marketwatch.comOxford BioMedica Shares Rise on Transformational Deal Talks, Revenue Growth ExpectationSeptember 20, 2023 | finance.yahoo.comOxford Biomedica and Institut Mérieux enter into exclusive negotiations with respect to the proposed acquisition by Oxford Biomedica of ABL Europe from Institut Mérieux as part of pure-play CDMO transformationSeptember 20, 2023 | finance.yahoo.comKyverna Therapeutics and Oxford Biomedica Sign License and Supply Agreement for LentiVector® PlatformSeptember 7, 2023 | finance.yahoo.comOxford Biomedica to host webinar showcasing the TetraVecta™ systemJuly 10, 2023 | finance.yahoo.comOxford Biomedica (LON:OXB) shareholders have endured a 50% loss from investing in the stock five years agoJune 23, 2023 | marketwatch.comOxford BioMedica's Executive Pay Report Gets Low Shareholder Support at Annual MeetingFebruary 20, 2023 | finance.yahoo.comDr Frank Mathias to join Oxford Biomedica as new CEO on 27 March 2023January 30, 2023 | finance.yahoo.comThe past year for Oxford Biomedica (LON:OXB) investors has not been profitableNovember 14, 2022 | finance.yahoo.comOxford Biomedica to complete sale and leaseback of Windrush Court facility for £60 millionSeptember 15, 2022 | lse.co.ukOxford BioMedica swings to interim loss as costs climb, revenue fallsAugust 19, 2022 | finance.yahoo.comOxford Biomedica (LON:OXB) shareholders have endured a 66% loss from investing in the stock a year agoJuly 26, 2022 | lse.co.ukOxford BioMedica begins new project and signs license agreementJuly 26, 2022 | finance.yahoo.comOxford Biomedica Signs Licence & Supply Agreement with New Partner for LentiVector® Platform for CAR-T TherapySee More Headlines Receive OXBDF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oxford Biomedica and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/18/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private households Sub-IndustryN/A Current SymbolOTCMKTS:OXBDF Previous SymbolNASDAQ:OXBDF CUSIPN/A CIKN/A Webwww.oxfordbiomedica.co.uk Phone44-18-6578-3000FaxN/AEmployees891Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$173.19 million Price / Sales2.28 Cash FlowN/A Price / Cash FlowN/A Book Value$3.03 per share Price / Book1.35Miscellaneous Outstanding Shares96,260,000Free FloatN/AMarket Cap$394.67 million OptionableNot Optionable Beta1.25 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Stuart Paynter (Age 52)CFO & Director Comp: $1.05MDr. Frank Mathias (Age 62)CEO & Director Mr. Thierry CournezCOO & Site Head of UK OperationsDr. James Miskin Ph.D.Chief Quality & Technical OfficerMr. Matthew TreagusChief Information Officer & Chief of StaffSophia BolhassanHead of Investor RelationsMs. Natalie Louise Walter (Age 51)General Counsel & Company Secretary Ms. Lisa JamesChief People OfficerDr. Kyriacos Mitrophanous Ph.D.Chief Innovation OfficerMs. Kati HudsonHead of Intellectual Property and ContractsMore ExecutivesKey CompetitorsKonica MinoltaOTCMKTS:KNCAYams-OSRAMOTCMKTS:AMSSYBR Malls ParticipaçõesOTCMKTS:BRMSYFirstGroupOTCMKTS:FGROYDundee Precious MetalsOTCMKTS:DPMLFView All Competitors OXBDF Stock Analysis - Frequently Asked Questions Should I buy or sell Oxford Biomedica stock right now? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oxford Biomedica in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" OXBDF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OXBDF, but not buy additional shares or sell existing shares. View OXBDF analyst ratings or view top-rated stocks. How have OXBDF shares performed in 2024? Oxford Biomedica's stock was trading at $2.69 on January 1st, 2024. Since then, OXBDF shares have increased by 52.4% and is now trading at $4.10. View the best growth stocks for 2024 here. Are investors shorting Oxford Biomedica? Oxford Biomedica saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 100 shares, a decrease of 80.0% from the April 30th total of 500 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 1.0 days. View Oxford Biomedica's Short Interest. How do I buy shares of Oxford Biomedica? Shares of OXBDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:OXBDF) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages...Weiss Ratings | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredThe Scary Fed Idea To Turn Your Dollars Into a Digital Power GrabCash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with t...Oasis Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Biomedica plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Biomedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.